Completed NA INTERVENTIONAL 2-arm NCT00136812

Treating Tobacco Dependence in Inpatient Psychiatry - 1

Treating Tobacco Dependence in Inpatient Psychiatry

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Tobacco Use Cessation Tobacco Use Disorder

Interventions stage-tailored intervention

Updated 8 times since 2017 Last updated: Mar 15, 2024 Started: Jul 31, 2006 Primary completion: Apr 30, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Tobacco Use Cessation and Tobacco Use Disorder and is currently completed. National Institute on Drug Abuse (NIDA) leads this study, which shows 8 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2024 — Jul 2024 [monthly]

Completed NA

Phase: PHASE2 → NA
Jan 2023 — May 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
Stanford University
University of California, San Francisco

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States